IP
IDXX icon

Isthmus Partners’s Idexx Laboratories IDXX Stock Holding History

Isthmus Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,777
Closed -$916K – 166
2019
Q1 		$916K Buy
+12,777
New +$2.64M 0.22% 93
2018
Q4 		– Sell
-115
Closed -$29K – 206
2018
Q3 		$29K Hold
115
– – 0.01% 208
2018
Q2 		$25K Hold
115
– – 0.01% 205
2018
Q1 		$22K Hold
115
– – 0.01% 205
2017
Q4 		$18K Buy
+115
New +$18.1K ﹤0.01% 214

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Isthmus Partners's IDXX Position: Q2 2019 in Review

Isthmus Partners sold out of Idexx Laboratories (IDXX) in Q2 2019, closing a stake of 12,777 shares — an estimated $916K sold.

Isthmus Partners first reported a position in IDXX in Q4 2017 and held it in 5 quarters. The position peaked at $916K in Q1 2019. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2019.

  • Isthmus Partners reported no remaining Idexx Laboratories position as of Q2 2019 after selling out during the quarter.
  • Isthmus Partners sold 12,777 Idexx Laboratories shares in Q2 2019, an estimated $916K.
  • Isthmus Partners first reported a position in Idexx Laboratories in Q4 2017 and held it in 5 quarters.
  • Isthmus Partners's Idexx Laboratories position peaked at $916K in Q1 2019.
  • 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2019.

Based on Isthmus Partners's 13F filing for Q2 2019, filed 9 Aug 2019.